Why Partner with SimBioSys?
Understanding why or why not a patient responds to a specific therapy remains a challenge and assessing the heterogeneity within tumors remains critical for the entire development lifecycle.
Current techniques do not account for the multiple scales and mechanisms of cancer.
SimBioSys TumorScope platform enables drug developers to capture tumor biology and heterogeneity to predict responses to therapy, providing more comprehensive insights, signatures and biomarkers than ex vivo or in vitro techniques alone.
Predict Response to Therapy
Predict endpoints such as objective response rate to therapy in silico and assess the incremental benefit of experimental agents

Novel Insights & Biomarkers
Combine all major hallmarks of cancer variation for a comprehensive approach to patient stratification including drug delivery, drug sensitivity, tumor metabolism and spatial heterogeneity
SimBioSys’ multidimensional approach bridges the gap between preclinical techniques and humans
Enhancing Translational Research & Drug Development
Proprietary models & services that can be utilized individually or as a platform
Supporting All Stages of Drug Development
SimBioSys is supporting the fight against cancer from idea to commercialization. Its ability to model, simulate and predict tumor response to therapies makes it an essential tool for pharmaceutical developers at every stage of the development cycle


Discovery Platform
- Genome-to-Phenome Insights
- Multiscale data analysis and visualization
- Customizable, Cloud-Scaling Computational Biology Workflows
- Contextualizing Novel Data

Regulated Clinical Tool
- In Silico Drug Testing
- Clinical Trial Selection
- Synthetic Control Arm Design
- Novel Biomarker Development